Anirban Basu

Names

Identifer

Contact

Affiliations

• University of Washington -Depts of Pharmacy, Health Services, Economics (weight: 10%)
  • https://sop.washington.edu/department-of-pharmacy/pharmaceutical-outcomes-research-policy-program-porpp/about/
  • location: Seattle, WA

Research profile

author of:

• IVCHECK: Stata module to choose between OLS and contaminated IV
  Statistical Software Components, Boston College Department of Economics (2014)
  by Anirban Basu
  (ReDIF-software, boc:bocode:s457840)
• Personalized Medicine in the Context of Comparative Effectiveness Research
  Forum for Health Economics & Policy, De Gruyter (2013)
  by Basu Anirban
  (ReDIF-article, bpj:fhecpo:v:16:y:2013:i:2:p:107-120:n:1)
• Generalized modeling approaches to risk adjustment of skewed outcomes data
  Journal of Health Economics, Elsevier (2005)
  by Manning, Willard G. & Basu, Anirban & Mullahy, John
  (ReDIF-article, eee:jhecon:v:24:y:2005:i:3:p:465-488)
• Implications of spillover effects within the family for medical cost-effectiveness analysis
  Journal of Health Economics, Elsevier (2005)
  by Basu, Anirban & Meltzer, David
  (ReDIF-article, eee:jhecon:v:24:y:2005:i:4:p:751-773)
• Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling
  Journal of Health Economics, Elsevier (2008)
  by Terza, Joseph V. & Basu, Anirban & Rathouz, Paul J.
  (ReDIF-article, eee:jhecon:v:27:y:2008:i:3:p:531-543)
• Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care
  Journal of Health Economics, Elsevier (2011)
  by Basu, Anirban
  (ReDIF-article, eee:jhecon:v:30:y:2011:i:3:p:549-559)
• The impact of comparative effectiveness research on health and health care spending
  Journal of Health Economics, Elsevier (2011)
  by Basu, Anirban & Jena, Anupam B. & Philipson, Tomas J.
  (ReDIF-article, eee:jhecon:v:30:y:2011:i:4:p:695-706)
• Welfare implications of learning through solicitation versus diversification in health care
  Journal of Health Economics, Elsevier (2015)
  by Basu, Anirban
  (ReDIF-article, eee:jhecon:v:42:y:2015:i:c:p:165-173)
• Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data
  Working Papers, Harris School of Public Policy Studies, University of Chicago (2003)
  by Willard G. Manning & Anirban Basu & John Mullahy
  (ReDIF-paper, har:wpaper:0313)
• Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data
  NBER Technical Working Papers, National Bureau of Economic Research, Inc (2003)
  by Willard G. Manning & Anirban Basu & John Mullahy
  (ReDIF-paper, nbr:nberte:0293)
• Use of Propensity Scores in Non-Linear Response Models: The Case for Health Care Expenditures
  NBER Working Papers, National Bureau of Economic Research, Inc (2008)
  by Anirban Basu & Daniel Polsky & Willard G. Manning
  (ReDIF-paper, nbr:nberwo:14086)
• The impact of Medicare Part D on Medicare-Medicaid Dual-eligible Beneficiaries' Prescription Utilization and Expenditures
  NBER Working Papers, National Bureau of Economic Research, Inc (2008)
  by Anirban Basu & Wesley Yin & G. Caleb Alexander
  (ReDIF-paper, nbr:nberwo:14413)
• The Impact of Comparative Effectiveness Research on Health and Health Care Spending
  NBER Working Papers, National Bureau of Economic Research, Inc (2010)
  by Anirban Basu & Tomas J. Philipson
  (ReDIF-paper, nbr:nberwo:15633)
• Economics of Individualization in Comparative Effectiveness Research and a Basis for a Patient-Centered Health Care
  NBER Working Papers, National Bureau of Economic Research, Inc (2011)
  by Anirban Basu
  (ReDIF-paper, nbr:nberwo:16900)
• Estimating Person-Centered Treatment (PeT) Effects Using Instrumental Variables
  NBER Working Papers, National Bureau of Economic Research, Inc (2012)
  by Anirban Basu
  (ReDIF-paper, nbr:nberwo:18056)
• Welfare Implications of Learning Through Solicitation versus Diversification in Health Care
  NBER Working Papers, National Bureau of Economic Research, Inc (2014)
  by Anirban Basu
  (ReDIF-paper, nbr:nberwo:20376)
• Political Polarization, Anticipated Health Insurance Uptake and Individual Mandate: A view from the Washington State
  NBER Working Papers, National Bureau of Economic Research, Inc (2014)
  by Anirban Basu & Norma B. Coe & David E. Grembowski & Larry Kessler
  (ReDIF-paper, nbr:nberwo:20655)
• The Roles of Cognitive and Non-Cognitive Skills in Moderating the Effects of Mixed-Ability Schools on Long-Term Health
  NBER Working Papers, National Bureau of Economic Research, Inc (2014)
  by Anirban Basu & Andrew M. Jones & Pedro Rosa Dias
  (ReDIF-paper, nbr:nberwo:20811)
• Price Elasticities of Pharmaceuticals in a Value-Based-Formulary Setting
  NBER Working Papers, National Bureau of Economic Research, Inc (2016)
  by Kai Yeung & Anirban Basu & Ryan N. Hansen & Sean D. Sullivan
  (ReDIF-paper, nbr:nberwo:22308)
• Comparing 2SLS vs 2SRI for Binary Outcomes and Binary Exposures
  NBER Working Papers, National Bureau of Economic Research, Inc (2017)
  by Anirban Basu & Norma Coe & Cole G. Chapman
  (ReDIF-paper, nbr:nberwo:23840)
• Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion
  NBER Working Papers, National Bureau of Economic Research, Inc (2017)
  by Caroline S. Bennette & Anirban Basu & Scott D. Ramsey & Zachary Helms & Peter B. Bach
  (ReDIF-paper, nbr:nberwo:23842)
• Service-level Selection: Strategic Risk Selection in Medicare Advantage in Response to Risk Adjustment
  NBER Working Papers, National Bureau of Economic Research, Inc (2017)
  by Sungchul Park & Anirban Basu & Norma Coe & Fahad Khalil
  (ReDIF-paper, nbr:nberwo:24038)
• The New Prescription Drug Paradox: Pipeline Pressure and Rising Prices
  NBER Working Papers, National Bureau of Economic Research, Inc (2018)
  by Alice M. Ellyson & Anirban Basu
  (ReDIF-paper, nbr:nberwo:24387)
• Impact of Rural and Urban Hospital Closures on Inpatient Mortality
  NBER Working Papers, National Bureau of Economic Research, Inc (2019)
  by Kritee Gujral & Anirban Basu
  (ReDIF-paper, nbr:nberwo:26182)
• Understanding Algorithmic Discrimination in Health Economics Through the Lens of Measurement Errors
  NBER Working Papers, National Bureau of Economic Research, Inc (2021)
  by Anirban Basu & Noah Hammarlund & Sara Khor & Aasthaa Bansal
  (ReDIF-paper, nbr:nberwo:29413)
• Hidden Figures: Uncovering Quantities Behind Zeros with Econometrics
  NBER Working Papers, National Bureau of Economic Research, Inc (2023)
  by Anirban Basu
  (ReDIF-paper, nbr:nberwo:31632)
• Do For-Profit Hospitals Cream-Skim Patients? Evidence from Inpatient Psychiatric Care in California
  NBER Working Papers, National Bureau of Economic Research, Inc (2024)
  by Donghoon Lee & Anirban Basu & Jerome A. Dugan & Pinar Karaca-Mandic
  (ReDIF-paper, nbr:nberwo:32179)
• Dynamic Efficiency and Pricing of Innovations with Insurance: The Case for Gene Therapies
  NBER Working Papers, National Bureau of Economic Research, Inc (2024)
  by Anirban Basu
  (ReDIF-paper, nbr:nberwo:32480)
• Does Competition under Medicare Prospective Payment Selectively Reduce Expenditures on High-Cost Patients?
  RAND Journal of Economics, The RAND Corporation (2002)
  by David Meltzer & Jeanette Chung & Anirban Basu
  (ReDIF-article, rje:randje:v:33:y:2002:i:autumn:p:447-468)
• Private Manufacturers’ Thresholds to Invest in Comparative Effectiveness Trials
  PharmacoEconomics, Springer (2012)
  by Anirban Basu & David Meltzer
  (ReDIF-article, spr:pharme:v:30:y:2012:i:10:p:859-868)
• Measuring the Value of Pharmaceuticals in the US Health System
  PharmacoEconomics, Springer (2017)
  by Surrey M. Walton & Anirban Basu & John Mullahy & Samuel Hong & Glen T. Schumock
  (ReDIF-article, spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-016-0463-3)
• Person-centered treatment (PeT) effects: Individualized treatment effects using instrumental variables
  Stata Journal, StataCorp LP (2015)
  by Anirban Basu
  (ReDIF-article, tsj:stataj:v:15:y:2015:i:2:p:397-410)
• Extended generalized linear models: Simultaneous estimation of flexible link and variance functions
  Stata Journal, StataCorp LP (2005)
  by Anirban Basu
  (ReDIF-article, tsj:stataj:v:5:y:2005:i:4:p:501-516)
• Comparing alternative models: log vs Cox proportional hazard?
  Health Economics, John Wiley & Sons, Ltd. (2004)
  by Anirban Basu & Willard G. Manning & John Mullahy
  (ReDIF-article, wly:hlthec:v:13:y:2004:i:8:p:749-765)
• Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity
  Health Economics, John Wiley & Sons, Ltd. (2006)
  by Anirban Basu & Bhakti V. Arondekar & Paul J. Rathouz
  (ReDIF-article, wly:hlthec:v:15:y:2006:i:10:p:1091-1107)
• Estimating lifetime or episode‐of‐illness costs under censoring
  Health Economics, John Wiley & Sons, Ltd. (2010)
  by Anirban Basu & Willard G. Manning
  (ReDIF-article, wly:hlthec:v:19:y:2010:i:9:p:1010-1028)
• Erratum: Estimating lifetime or episode‐of‐illness costs under censoring
  Health Economics, John Wiley & Sons, Ltd. (2011)
  by Anirban Basu & Willard G. Manning
  (ReDIF-article, wly:hlthec:v:20:y:2011:i:1:p:125-126)
• Highlighting Differences Between Conditional And Unconditional Quantile Regression Approaches Through An Application To Assess Medication Adherence
  Health Economics, John Wiley & Sons, Ltd. (2013)
  by Bijan J. Borah & Anirban Basu
  (ReDIF-article, wly:hlthec:v:22:y:2013:i:9:p:1052-1070)
• Heterogeneity In Action: The Role Of Passive Personalization In Comparative Effectiveness Research
  Health Economics, John Wiley & Sons, Ltd. (2014)
  by Anirban Basu & Anupam B. Jena & Dana P. Goldman & Tomas J. Philipson & Robert Dubois
  (ReDIF-article, wly:hlthec:v:23:y:2014:i:3:p:359-373)
• Response To Epstein'S Comment On “Heterogeneity In Action”
  Health Economics, John Wiley & Sons, Ltd. (2014)
  by Anirban Basu & Anupam B. Jena & Dana P. Goldman & Tomas J. Philipson & Robert Dubois
  (ReDIF-article, wly:hlthec:v:23:y:2014:i:3:p:376-378)
• Can We Make Smart Choices Between Ols And Contaminated Iv Methods?
  Health Economics, John Wiley & Sons, Ltd. (2014)
  by Anirban Basu & Kwun Chuen Gary Chan
  (ReDIF-article, wly:hlthec:v:23:y:2014:i:4:p:462-472)
• ESTIMATING PERSON‐CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS
  Journal of Applied Econometrics, John Wiley & Sons, Ltd. (2014)
  by Anirban Basu
  (ReDIF-article, wly:japmet:v:29:y:2014:i:4:p:671-691)
• Use of instrumental variables in the presence of heterogeneity and self-selection: An application in breast cancer patients
  Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York (2007)
  by Anirban Basu & James J. Heckman & Salvador Navarro-Lozano & Sergio Urzua
  (ReDIF-paper, yor:hectdg:07/07)
• Use of propensity scores in non-linear response models: The case for health care expenditures
  Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York (2008)
  by Basu, A & Polsky, D & Manning, W G
  (ReDIF-paper, yor:hectdg:08/11)
• Estimating Lifetime or Episode-of-illness Costs
  Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York (2009)
  by Basu A & Manning WG
  (ReDIF-paper, yor:hectdg:09/12)
• Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality
  Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York (2011)
  by Evans, H. & Basu, A
  (ReDIF-paper, yor:hectdg:11/08)
• Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality
  Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York (2011)
  by H. Evans & A. Basu
  (ReDIF-paper, yor:hectdg:11/26)